Farms.com Home   News

Grain Growers of Canada call for rapid ratification of CUSMA

OTTAWA – Grain Growers of Canada (GGC) is urging both Houses of Parliament to pass legislation and quickly ratify the Canada-United States-Mexico Agreement (CUSMA) to begin realizing the benefits of this historic agreement.
 
“Our farmer members across Canada need certainty to invest and grow,” said GGC Chair Jeff Nielsen from his farm near Olds, AB. “This is why Government must pass this legislation before summer break to ensure our North American market access is preserved. The success of Canadian agriculture is not a partisan issue and we urge all parties to work together to see the legislation through”
 
If the bill to ratify CUSMA, called Bill C-100, is passed this week, it will represent a meaningful upgrade to the North American Free Trade Agreement (NAFTA) for Canadian agriculture by keeping our trade with the United States and Mexico tariff free. The CUSMA will also remove legal barriers that prevent grain grown in the US from being treated equally here – a longstanding request from grain farmers on both sides of the border.
 
“We need tariff-free access for our export commodities as soon as possible,” continued Mr. Nielsen. “Canadian farmers rely on stable markets to succeed and ratifying the CUSMA will allow us to capitalize on further opportunities for growth with our closest trading partners.”
 
GGC will continue, in conjunction with our partners within the Canadian Agri-Food Trade Alliance (CAFTA), to advocate for the timely passage of Bill C-100.
 
Source : Grain Growers Of Canada

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.